SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

UE, Ana Paula Fusel de et al. Estudo da qualidade de vida nos pacientes com urticária crônica. An. Bras. Dermatol. [online]. 2011, vol.86, n.5, pp. 879-904. ISSN 0365-0596.  http://dx.doi.org/10.1590/S0365-05962011000500006.

    1. Zuberbier T, Greaves MW, Juhlin L, Kobza-Black A, Maurer D, Stingl G, et al. Definition, classification, and routine diagnosis of urticaria: a consensus report. J Investig Dermatol Symp Proc. 2001;6:123-127. [ Links ]

    2. Grattan CEH. The urticaria spectrum: recognition of clinical patterns can help management. Clin Exp Dermatol 2004;29:217-21. [ Links ]

    3. Grattan CEH, Sabroe RA, Greaves MW. Chronic urticaria. J Am Acad Dermatol. 2002;46:645-57. [ Links ]

    4. Souza PK. Urticária crônica: estudo clínico e laboratorial de 216 casos [tese]. São Paulo: Universidade Federal de São Paulo; 1999. [ Links ]

    5. Greaves MW. Pathophysiology of Chronic urticaria. Int Arch Allergy Immunol. 2002;127:3-9. [ Links ]

    6. Kozel MMA, Sabroe RA. Chronic Urticaria. Etiology, management and current and future treatment options. Drugs. 2004;64:2515-36. [ Links ]

    7. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol. 2004;114:465-74. [ Links ]

    8. Dibbern Jr DA, Dreskin SC. Urticaria and angioedema: an overview. Immunol Allergy Clin North Am. 2004;24:141-62. [ Links ]

    9. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997;136:197-201. [ Links ]

    10. Finlay AY, Khan GK. Dermatology life quality index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-6. [ Links ]

    11. Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous disease. J Am Acad Dermatol. 1997;37:41-50. [ Links ]

    12. Chren MM, Lasek RJ, Quin LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity and responsiveness. J Invest Dermatol 1996;107:707-13. [ Links ]

    13. Evers AW, Duller P, van der Kerkhof PC, van der Valk PG, der Jong EM, Gerritsen MJ, et al. The impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatologic-specific health instrument. Br J Dermatol. 2008;158:101-8. [ Links ]

    14. Le Cleach L, Chassany O, Levy A, Wolkenstein P, Chosidow O. Poor reporting of quality of life outcomes in dermatology randomized controlled clinical trials. Dermatology. 2008;216:46-55. [ Links ]

    15. Poon E, Seed PT, Greaves MW, Black AK. The extent and nature of disability in different urticarial conditions. Br J Dermatol. 1999;140:667-71. [ Links ]

    16. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol. 1999;39:143-50. [ Links ]

    17. Ferraz LB, Almeida FA, Vasconcellos MR, Facina AS, Ciconelli RM, Ferraz MB. The impact of lupus erythematosus cutaneous on the Quality of Life: The Brazilian-Portuguese version of DLQI. Qual Life Res. 2006;15:565-70. [ Links ]

    18. Ware JE, Sherbourne CD. The MOS 36 Item Short- Form Health Survey (SF-36). Conceptual framework and item selection. Med Care.1992;30:473-83. [ Links ]

    19. The World Health Organization Quality of Life assessment (WHOQOL): development and general psychometric properties. Soc. Sci. Med. 1998;46:1569-85. [ Links ]

    20. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273:59-65 [ Links ]

    21. Halioua B, Beumont MG, Lunel F. Quality of life in dermatology. Int J Dermatol. 2000;39:801-6. [ Links ]

    22. Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med. 1996;334:835-840. [ Links ]

    23. Finlay AY. Quality of life measurement in dermatology: a pratical guide. Br J Dermatol. 1997;136:305-14. [ Links ]

    24. Baiardini I, Giardini A, Pasquali M, Dignetti P, Guerra L , Specchia C, et al. Quality of life and patient's satisfaction in chronic urticaria and respiratory allergy. Allergy. 2003;58:621-3. [ Links ]

    25. Grob JJ, Auquier P, Dreyfus I, Ortonne JP. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadina daily vs PRN and quality of life. Allergy. 2009;64:605-12. [ Links ]

    26. Ozkan M, Oflaz SB, Kocaman N, Ozseker F, Gelincik A, Büyüköztürk S, et al. Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2007;99:29-33. [ Links ]

    27. Taborda ML, Weber MB, Teixeira KAM, Lisboa AP, Welter EQ. Avaliação da qualidade de vida e do sofrimento psíquico de pacientes com diferentes dermatoses em um centro de referência em dermatologia no sul do país. An Bras Dermatol. 2010;85:52-6. [ Links ]

    28. Thompson AK, Finn AF, Schoenwetter WF. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J Am Acad Dermatol. 2000;43:24-30. [ Links ]

    29. Lachapelle JM, Decroix J, Henrijean A, Roquet-Gravy PP, De Swerdt A, Boonen H, et al. Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol. 2006;20:288-92. [ Links ]

    30. Mlynek A, Magerl M, Hanna M, Lhachimi S, Baiardini I, Canonica GW et al. The German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findings. Allergy. 2009;64:927-36. [ Links ]